Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Myocardium and endocardium of the early mammalian heart tube arise from independent multipotent lineages specified at the primitive streak.

  • Sendra, Miquel
  • McDole, Katie
  • de Dios Hourcade, Juan
  • Temiño, Susana
  • Raiola, Morena
  • Guignard, Léo
  • Keller, Philipp J
  • Domínguez, Jorge N
  • Torres, Miguel
The formation of the primitive heart tube from cardiomyocytes and endocardial cells is a key event in mammalian development. Previous studies suggested that cardiomyocytes and endocardial cells segregate from a shared cardiac progenitor around the onset of gastrulation, yet their lineage relationship with other mesodermal tissues remains unclear. Using retrospective and prospective clonal analyses in mouse embryos, we traced cardiomyocyte and endocardial progenitors from the primitive streak to the heart tube. Our results identify two independent mesodermal populations specified around gastrulation onset. While each of these populations is unipotent in producing cardiomyocytes or endocardium, they retain multipotency and contribute to different subsets of non-cardiac mesoderm. Nonetheless, live imaging identifies simultaneous ingression and intermingling of these two mesodermal lineages in the primitive streak, showing their coordinated specification and migration. The proposed model for cardiac progenitor specification will help understanding the origins of congenital heart diseases and designing tissue engineering strategies.
Repisalud
Publication Artículo científico (JournalArticle)

Meis transcription factors regulate cardiac conduction system development and adult function.

  • Muñoz-Martín, Noelia
  • Simon-Chica, Ana
  • Díaz-Díaz, Covadonga
  • Cadenas, Vanessa
  • Temiño, Susana
  • Esteban, Isaac
  • Ludwig, Andreas
  • Schormair, Barbara
  • Winkelmann, Juliane
  • Olejnickova, Veronika
  • Sedmera, David
  • Filgueiras-Rama, David
  • Torres, Miguel
The cardiac conduction system (CCS) is progressively specified during development by interactions among a discrete number of transcription factors (TFs) that ensure its proper patterning and the emergence of its functional properties. Meis genes encode homeodomain TFs with multiple roles in mammalian development. In humans, Meis genes associate with congenital cardiac malformations and alterations of cardiac electrical activity; however, the basis for these alterations has not been established. Here, we studied the role of Meis TFs in cardiomyocyte development and function during mouse development and adult life. We studied Meis1 and Meis2 conditional deletion mouse models that allowed cardiomyocyte-specific elimination of Meis function during development and inducible elimination of Meis function in cardiomyocytes of the adult CCS. We studied cardiac anatomy, contractility, and conduction. We report that Meis factors are global regulators of cardiac conduction, with a predominant role in the CCS. While constitutive Meis deletion in cardiomyocytes led to congenital malformations of the arterial pole and atria, as well as defects in ventricular conduction, Meis elimination in cardiomyocytes of the adult CCS produced sinus node dysfunction and delayed atrio-ventricular conduction. Molecular analyses unravelled Meis-controlled molecular pathways associated with these defects. Finally, we studied in transgenic mice the activity of a Meis1 human enhancer related to an single-nucleotide polymorphism (SNP) associated by Genome-wide association studies (GWAS) to PR (P and R waves of the electrocardiogram) elongation and found that the transgene drives expression in components of the atrio-ventricular conduction system. Our study identifies Meis TFs as essential regulators of the establishment of cardiac conduction function during development and its maintenance during adult life. In addition, we generated animal models and identified molecular alterations that will ease the study of Meis-associated conduction defects and congenital malformations in humans.
Repisalud
Publication Artículo científico (JournalArticle)

Epicardial VEGFC/D signaling is essential for coronary lymphangiogenesis.

  • de la Cruz, Ester
  • Cadenas, Vanessa
  • Temiño, Susana
  • Oliver, Guillermo
  • Torres, Miguel
The contractile ability of the mammalian heart critically relies on blood coronary circulation, essential to provide oxygen and nutrients to myocardial cells. In addition, the lymphatic vasculature is essential for the myocardial immune response, extracellular fluid homeostasis and response to injury. Recent studies identified different origins of coronary lymphatic endothelial cells, however, the cues that govern coronary lymphangiogenesis remain unknown. Here we show that the coronary lymphatic vasculature develops in intimate contact with the epicardium and with epicardial-derived cells. The epicardium expresses the lymphangiogenic cytokine VEGFC and its conditional deletion in the epicardium abrogates coronary lymphatic vasculature development. Interestingly, VEGFD is also expressed in the epicardium and cooperates with VEGFC in coronary lymphangiogenesis, but it does so only in females, uncovering an unsuspected sex-specific role for this cytokine. These results identify the epicardium/subepicardium as a signaling niche required for coronary lymphangiogenesis and VEGFC/D as essential mediators of this role.
Repisalud
Publication Artículo científico (JournalArticle)

Spns1-dependent endocardial lysosomal function drives valve morphogenesis through Notch1-signaling.

  • Chávez, Myra N
  • Arora, Prateek
  • Meer, Marco
  • Marques, Ines J
  • Ernst, Alexander
  • Morales Castro, Rodrigo A
  • Mercader, Nadia
Autophagy-lysosomal degradation is a conserved homeostatic process considered to be crucial for cardiac morphogenesis. However, both its cell specificity and functional role during heart development remain unclear. Here, we introduced zebrafish models to visualize autophagic vesicles and track their temporal and cellular localization in the larval heart. We observed a significant accumulation of autolysosomal and lysosomal vesicles in the atrioventricular and bulboventricular regions and their respective valves. We addressed the role of lysosomal degradation based on the Spinster homolog 1 () mutant (, ). larvae displayed morphological and functional cardiac defects, including abnormal endocardial organization, impaired valve formation and retrograde blood flow. Single-nuclear transcriptome analyses revealed endocardial-specific differences in lysosome-related genes and alterations of signalling. Endocardial-specific overexpression of and rescued features of valve formation and function. Altogether, our results reveal a cell-autonomous role of lysosomal processing during cardiac valve formation affecting signalling.
Repisalud
Publication Artículo científico (JournalArticle)

Modulation of cardiomyocyte contractility and action potentials with chemogenetic chloride currents.

  • Sönmez, Muhammed
  • Stüdemann, Tim
  • Manthey, Christoph
  • Covic, Anita
  • Shehata, Nancy
  • Im, Junsoo
  • Schwarzova, Barbora
  • Rössinger, Judith
  • Srikantharajah, Rajiven
  • Shibamiya, Aya
  • Schwedhelm, Edzard
  • Eschenhagen, Thomas
  • Christ, Torsten
  • Weinberger, Florian
Transient perturbation of electrical activity is used in neuroscience to study the impact of specific neuronal cell populations on brain function. Similarly, cardiomyocyte (CM) physiology can be controlled by the activation of artificially expressed ion channels. Pharmacologically selective actuator modules (PSAMs) are engineered ligand-gated ion channels that can be activated with small molecules. We aimed to use the 'inhibitory' PSAMs, (i) PSAM (PSAM-GlyR) and (ii) PSAM (ultrapotent PSAM-GlyR), which consist of modified α7-nicotinergic acetylcholine receptor ligand binding domains and the ion pore domain of the glycine receptor, to modulate CM physiology with chloride currents. We employed CRISPR/Cas9 to integrate PSAM-GlyR and PSAM-GlyR in induced pluripotent stem cells, differentiated CMs and generated engineered heart tissue (EHT). Video optical force recordings, sharp microelectrode action potential measurements and patch-clamp technique were used to characterize PSAM-GlyR and PSAM-GlyR CMs. PSAM-GlyR and PSAM-GlyR activation allowed titration of chloride currents in a reversible manner. We found that chloride currents modulated action potential characteristics. Patch clamp recordings showed that channel activation resulted in chloride-driven currents that depolarized the cell. In EHT, this resulted in a stop of contractility that was fully reversible after wash-out. We provide a comprehensive characterization of the chemogenetic tools PSAM-GlyR and PSAM-GlyR in CMs, demonstrating their utility to modulate CM activity in vitro (PSAM-GlyR and PSAM-GlyR) but also potential for in vivo applications (PSAM-GlyR). KEY POINTS: Pharmacologically selective actuator modules (PSAMs) are engineered ligand-gated ion channels that can be activated with small molecules. These chemogenetic tools have been applied in neuroscience to inhibit neuronal activity. Chemogenetic tools can also be used to modulate cardiomyocyte physiology. Activation of the PSAMs, PSAM-GlyR and PSAM-GlyR depolarized cardiomyocytes and thus stopped cardiac contractility. Our study characterizes novel tools that can be used to modulate cardiomyocyte physiology in vitro and in vivo.
Repisalud
Publication Artículo científico (JournalArticle)

ZebraReg-a novel platform for discovering regulators of cardiac regeneration using zebrafish.

  • Apolínová, Kateřina
  • Pérez, Ferran Arqué
  • Dyballa, Sylvia
  • Coppe, Benedetta
  • Mercader Huber, Nadia
  • Terriente, Javier
  • Di Donato, Vincenzo
Cardiovascular disease is the leading cause of death worldwide with myocardial infarction being the most prevalent. Currently, no cure is available to either prevent or revert the massive death of cardiomyocytes that occurs after a myocardial infarction. Adult mammalian hearts display a limited regeneration capacity, but it is insufficient to allow complete myocardial recovery. In contrast, the injured zebrafish heart muscle regenerates efficiently through robust proliferation of pre-existing myocardial cells. Thus, zebrafish allows its exploitation for studying the genetic programs behind cardiac regeneration, which may be present, albeit dormant, in the adult human heart. To this end, we have established ZebraReg, a novel and versatile automated platform for studying heart regeneration kinetics after the specific ablation of cardiomyocytes in zebrafish larvae. In combination with automated heart imaging, the platform can be integrated with genetic or pharmacological approaches and used for medium-throughput screening of presumed modulators of heart regeneration. We demonstrate the versatility of the platform by identifying both anti- and pro-regenerative effects of genes and drugs. In conclusion, we present a tool which may be utilised to streamline the process of target validation of novel gene regulators of regeneration, and the discovery of new drug therapies to regenerate the heart after myocardial infarction.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Regulation of Myc transcription by an enhancer cluster dedicated to pluripotency and early embryonic expression

  • Li-Bao, Lin
  • Díaz-Díaz, Covadonga
  • Raiola, Morena
  • Sierra, Rocío
  • Temiño, Susana
  • Moya, Francisco J.
  • Rodríguez-Perales, Sandra
  • Santos, Elisa
  • Giovinazzo, Giovanna
  • Bleckwehl, Tore
  • Rada-Iglesias, Álvaro
MYC plays various roles in pluripotent stem cells, including the promotion of somatic cell reprogramming to pluripotency, the regulation of cell competition and the control of embryonic diapause. However, how Myc expression is regulated in this context remains unknown. The Myc gene lies within a ~ 3-megabase gene desert with multiple cis-regulatory elements. Here we use genomic rearrangements, transgenesis and targeted mutation to analyse Myc regulation in early mouse embryos and pluripotent stem cells. We identify a topologically-associated region that homes enhancers dedicated to Myc transcriptional regulation in stem cells of the pre-implantation and early post-implantation embryo. Within this region, we identify elements exclusively dedicated to Myc regulation in pluripotent cells, with distinct enhancers that sequentially activate during naive and formative pluripotency. Deletion of pluripotency-specific enhancers dampens embryonic stem cell competitive ability. These results identify a topologically defined enhancer cluster dedicated to early embryonic expression and uncover a modular mechanism for the regulation of Myc expression in different states of pluripotency., Grants PGC2018-096486-B-I00 and PID2022-140058NB-C31 from the Agencia Estatal de Investigación to M.T.; European Commission H2020 Program grant SC1-BHC-07-2019. Ref. 874764 “REANIMA” to M.T. Comunidad de Madrid grant P2022/BMD-7245 CARDIOBOOST-CM to M.T. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia, Innovación y Universidades (MICIU) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIU/AEI/10.13039/501100011033)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001041-S)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

  • de Boer, Rudolf A..
  • Hulot, Jean-Sébastien
  • Tocchetti, Carlo Gabriele|||0000-0001-5983-688X
  • Aboumsallem, Joseph Pierre
  • Ameri, Pietro|||0000-0001-7167-7287
  • Anker, Stefan|||0000-0002-0805-8683
  • Bauersachs, Johann|||0000-0002-9341-117X
  • Bertero, Edoardo
  • Coats, Andrew J. S.
  • Čelutkienė, Jelena
  • Chioncel, O.|||0000-0002-3197-3628
  • Dodion, Pierre
  • Eschenhagen, Thomas
  • Farmakis, Dimitrios|||0000-0001-8364-3447
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Jäger, Dirk
  • Jankowska, Ewa A.
  • Kitsis, Richard N.
  • Konety, Suma H.
  • Larkin, James
  • Lehmann, Lorenz
  • Lenihan, Daniel J.
  • Maack, Christoph
  • Moslehi, Javid J.
  • Müller, Oliver J.
  • Nowak-Sliwinska, Patrycja
  • Piepoli, Massimo Francesco
  • Ponikowski, Piotr|||0000-0002-3391-7064
  • Pudil, Radek
  • Rainer, Peter P.|||0000-0002-2840-6454
  • Ruschitzka, Frank
  • Sawyer, Douglas
  • Seferovic, Petar M.
  • Suter, Thomas
  • Thum, Thomas|||0000-0003-4360-1511
  • van der Meer, Peter|||0000-0002-9705-4413
  • Van Laake, Linda W.
  • von Haehling, Stephan
  • Heymans, Stephane
  • Lyon, Alexander R.
  • Backs, Johannes|||0000-0002-2322-2699
The co-occurrence of cancer and heart failure (HF) represents a significant clinical drawback as each disease interferes with the treatment of the other. In addition to shared risk factors, a growing body of experimental and clinical evidence reveals numerous commonalities in the biology underlying both pathologies. Inflammation emerges as a common hallmark for both diseases as it contributes to the initiation and progression of both HF and cancer. Under stress, malignant and cardiac cells change their metabolic preferences to survive, which makes these metabolic derangements a great basis to develop intersection strategies and therapies to combat both diseases. Furthermore, genetic predisposition and clonal haematopoiesis are common drivers for both conditions and they hold great clinical relevance in the context of personalized medicine. Additionally, altered angiogenesis is a common hallmark for failing hearts and tumours and represents a promising substrate to target in both diseases. Cardiac cells and malignant cells interact with their surrounding environment called stroma. This interaction mediates the progression of the two pathologies and understanding the structure and function of each stromal component may pave the way for innovative therapeutic strategies and improved outcomes in patients. The interdisciplinary collaboration between cardiologists and oncologists is essential to establish unified guidelines. To this aim, pre-clinical models that mimic the human situation, where both pathologies coexist, are needed to understand all the aspects of the bidirectional relationship between cancer and HF. Finally, adequately powered clinical studies, including patients from all ages, and men and women, with proper adjudication of both cancer and cardiovascular endpoints, are essential to accurately study these two pathologies at the same time. We describe the co-occurrence of cancer and heart failure (HF), their potential shared risk factors, and their pathophysiological mechanisms. We advocate intense interaction between cardiologists and oncologists to achieve unifying hypotheses and collaborative pre-clinical and clinical studies.